Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System
IntroductionNew oral tyrosine kinase inhibitors (TKIs) are approved for metastatic colorectal cancer (mCRC). The aim of this study was to assess the neuropsychiatric adverse drug reactions (ADRs) of these drugs reported in the FDA Adverse Event Reporting System (FAERS) database.MethodsAll reports wi...
Main Authors: | Maria Antonietta Barbieri, Giulia Russo, Emanuela Elisa Sorbara, Giuseppe Cicala, Tindara Franchina, Mariacarmela Santarpia, Desirèe Speranza, Edoardo Spina, Nicola Silvestris |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1268672/full |
Similar Items
-
Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database
by: Giulia Russo, et al.
Published: (2023-08-01) -
Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System
by: Maria Antonietta Barbieri, et al.
Published: (2023-03-01) -
Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database
by: Maria Antonietta Barbieri, et al.
Published: (2022-11-01) -
NEUROPSYCHIATRIC ADVERSE EFFECTS OF HVC TREATMENT AND THEIR IMPACT ON THE TREATMENT RESPONSE
by: Sadia Qureshi, et al.
Published: (2017-06-01) -
Sex effects in predictors of smoking abstinence and neuropsychiatric adverse events in the EAGLES trial
by: Sherry A. McKee, et al.
Published: (2023-09-01)